(Q67769862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

14 November 2022

author name string

F. X. Kleber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746416

14 November 2022

L. Niemöller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746416

14 November 2022

M. Fischer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746416

14 November 2022

W. Doering

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746416

14 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

18 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1746416

full work available at URL

14 November 2022

https://api.elsevier.com/content/article/PII:000291499190269Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

https://api.elsevier.com/content/article/PII:000291499190269Q?httpAccept=text/plain

14 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

American Journal of Cardiology

14 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

121D-126D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

Diseases of the heart in the works of Hippocrates

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

14 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

14 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

The Natural History of Congestive Heart Failure: The Framingham Study

14 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

14 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

14 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

14 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

14 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Individualized care in patients with chronic congestive heart failure

14 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

14 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction

14 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

14 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease

14 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

14 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration

14 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition

14 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

14 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

14 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(91)90269-Q

14 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1746416%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference